Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
JPEN. Journal of Parenteral and Enteral Nutrition|November 1, 2008
The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic functionMilan C Richir, Roderick H Bouwman, Tom Teerlink, et al.The Urologic Clinics of North America|November 1, 1996
The role of the reverse-transcriptase polymerase chain reaction assay for prostate-specific antigen in the selection of patients for radical prostatectomyA E Katz, G M de Vries, M C Benson, et al.Journal of Clinical Pharmacology|June 23, 2015
A Delphi study among internal medicine clinicians to determine which therapeutic information is essential to record in a medical recordRobert J van Unen, Jelle Tichelaar, Prabath W B Nanayakkara, et al.The Journal of Urology|May 1, 1996
Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomyC A Olsson, G M de Vries, A J Raffo, et al.BMC Medical Education|January 27, 2017
Motivation and competence of participants in a learner-centered student-run clinic: an exploratory pilot studyTim Schutte, Jelle Tichelaar, Ramon S Dekker, et al.European Journal of Clinical Pharmacology|December 17, 2014
The effect of different levels of realism of context learning on the prescribing competencies of medical students during the clinical clerkship in internal medicine: an exploratory studyJelle Tichelaar, Coen van Kan, Robert J van Unen, et al.Cancer|April 1, 1995
Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancerA E Katz, G M de Vries, M D Begg, et al.Journal of Evaluation in Clinical Practice|August 14, 2015
Structure, importance and recording of therapeutic information in the medical record: a multicentre observational studyJelle Tichelaar, Robert J van Unen, David J Brinkman, et al.Cancer|June 15, 1997
Detection of circulating prostate carcinoma cells via an enhanced reverse transcriptase-polymerase chain reaction assay in patients with early stage prostate carcinoma. Independence from other pretreatment characteristicsR D Ennis, A E Katz, G M de Vries, et al.Journal of Evaluation in Clinical Practice|April 7, 2010
Therapeutic reasoning: from hiatus to hypothetical modelSanjay W Bissessur, Eric C T Geijteman, Muhammad Al-Dulaimy, et al.Pageof 5